Clinical Trials · NCT00288080

Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer

CompletedPhase 3Gonadorelin (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Radiation Therapy Oncology Group
Enrollment
612
Start date
Dec 2005
Locations
254 sites, United States, Canada
Primary endpoint
Overall Survival
View Gonadorelin compound reference